Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Toronto Western Hospital |
Maps & Directions
Assessment for Duodopa® therapy is performed in the Duodopa® Clinic at Toronto Western Hospital. This clinic is a part of The Edmond J. Safra Program in Parkinson's Disease and the Morton and
Gloria Shulman Movement Disorders Clinic.
It is located in the McLaughlin Pavilion – 7th Floor.
Patients deemed appropriate for Duodopa® therapy have insertion of the percutaneous endoscopic transgastric jejunostomy (PEG-J) performed in the Endoscopy Unit. This is an outpatient procedure held on the 4th floor East Wing. Initiation and titration of Duodopa® medication occurs approximately two weeks post PEG-J insertion at the Duodopa® Clinic on the 7th floor McLaughlin Pavilion.
Duodopa® is a treatment for advanced Parkinson's disease offered to patients when various combinations of Parkinson's medications are no longer sufficient to provide a good quality of life. For example, when the many doses of oral levodopa taken by the patient fail to keep them in their best state of mobility for enough of the waking day Duodopa® may be considered.
It can be used for Parkinson's disease in people who are responsive to oral levodopa treatment, but have substantial amount of "off" time without satisfactory control of severe, disabling motor and non-motor symptoms despite multiple doses of currently available oral medications. This treatment will not improve symptoms that are unresponsive to levodopa.
Duodopa® is a gel mixture of levodopa and carbidopa administered throughout the day with a portable pump into the small intestine via a permanent tube that passes through the abdominal wall, the stomach and into the small intestine (PEG-J). It allows a constant amount of levodopa to be present in the blood, which can reduce motor fluctuations therefore, decreasing the number of times patients alternate between significant "off" time and uncontrolled movement (dyskinesia).
After your assessment at the Duodopa® clinic is complete, your neurology team will:
A few weeks after you are referred to your gastroenterologist, you will meet him or her to:
Once you have met the gastroenterologist, their office will contact you to schedule:
How Duodopa® works
Duodopa® is administered throughout the waking day. The pump is connected in the morning and disconnected in the evening at bedtime. The Duodopa® system consists of 4 parts:
You will have a procedure done by the gastroenterologist to insert a combination of two tubes (PEG-J) through your stomach through the abdominal wall and into the small intestine. This is an outpatient procedure, and you will be discharged the same day. The day after the procedure, you will return to the clinic for evaluation of your PEG-J site.
Two-three weeks after PEG-J insertion, Duodopa® therapy will be initiated. The CADD-pump with the medication cassette will be attached to your PEG tube and over three consecutive days for 6-7 hours per day, you will be monitored at the Movement Disorders Clinic by your neurologist and nurse. The medication dosage will be titrated by your specialist team during this time. No hospital admission will be needed for these visits. The goal is to find the dose that gives you the best possible results. Dosing regimens are programmed into the pump on an individual basis.
In order to qualify for Duodopa®
Dr. A. Lang
Phone: 416 603 5800 ext. 6422
Dr. A. Fasano
Phone: 416 603 5800 ext. 5729
Phone: 416 603 5800 ext. 2637